Paul

About Paul Rowady

Paul Rowady is the Director of Research for Alphacution Research Conservatory, an institutional research and strategic advisory platform uniquely focused on modeling and benchmarking the impacts of technology on global financial markets and the businesses of trading and asset management. Based on an expanding research library focused on the modeling of specific market actors, composited industry segments, and key thematic drivers, the Alphacution platform is specifically designed to deliver data-driven and quantitatively based intelligence to a forward-thinking network of market participants and their stakeholders. Paul is a 35-year veteran of the proprietary, quantitative and derivatives trading arenas. Contact: feedback@alphacution.com.

Hudson River Trading Finally Sets A Hook

No doubt, options are the rage. Have been for a few years, thanks to an increasingly emboldened, crowd-sourced army of retail warriors - and timely new product developments by a consortium of exchanges, influential market makers, and other notable players in US equity options... The competition to play this game as a market maker is fierce. The cost of complexity makes this game difficult for smaller players - some of them highly experienced and long-time players - to afford to play successfully anymore. Some of these smaller players have voluntarily exited - or outright failed... Hudson River Trading, one of the speed demons originally confined largely to order flows on public exchanges (prior to its acquisition of Sun Trading in Jan 2018), appears - finally - to be defying those odds in options... In this Feed post, Alphacution paints a detailed picture by taking the "scenic route" through the roster of leading prop firms and hedge funds that enjoy significant share and wield significant influence in US equity options as context for HRT's latest achievements, competitive positioning, and challenges ahead...

By |2025-11-03T22:03:59-05:00October 31st, 2025|For Subscribers|

Dopamine Rush: CME, NYSE, Robinhood – Groping The Gamblers, Part II

Prediction markets - like Kalshi and Polymarket - are enjoying a beautiful day in the sun with all the new deal flow and attention from NYSE, CME, Robinhood and others. Now, the National Hockey League (NHL) is eagerly stepping up to be the first major US sports rights holder to drape itself in logo-embossed gambling. Alphacution shows the mechanics and real objectives of this sudden flurry of activity...

By |2025-10-24T19:39:13-04:00October 23rd, 2025|For Subscribers|

Approaching Peak Proprietary

Alphacution presents evidence for how dominant prop firms are starving smaller competitors out of business - a sign that we may be approaching some kind of peak. One of the highlights of this post is a rare, long-term chart of the rise of the top proprietary traders - including Citadel Securities, Jane Street Group, and Susquehanna International Group (SIG) - and the decline of banks in the US equity option market...

By |2025-10-10T22:26:26-04:00September 26th, 2025|For Subscribers|

Optiver’s Charm Offensive – Part I (Updated)

Bloomberg's recent exposé on legendary Amsterdam-based derivatives trader, Optiver, is heavy on gloss and sabre rattling - against market leaders like Citadel Securities, Jane Street, and Susquehanna International Group - and light on strategic and competitive analysis. In Part I of this Feed post, Alphacution begins to fill that gap with data, context, and perspective...

By |2025-09-04T18:07:45-04:00September 2nd, 2025|For Subscribers|